Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease

Clinical trial NCT04857606 · COMPLETED

Trial details

NCT number: NCT04857606
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2021-05-24
Primary completion: 2023-07-19
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.